Synapse

← Cardiovascular Endocrinology & Metabolism

Papers in Cardiovascular Endocrinology & Metabolism

Page 3 · newest first

  1. Sodium-glucose co-transporter 2 inhibitors and diabetic retinopathy: insights into preservation of sight and looking beyondCardiovascular Endocrinology & Metabolism · 2020
  2. Clinical presentation of paroxysmal supraventricular tachycardia: evaluation of usual and unusual symptomsCardiovascular Endocrinology & Metabolism · 2020
  3. A novel strategy to reduce the readmission rates in congestive heart failure: intermittent empirical intravenous diureticsCardiovascular Endocrinology & Metabolism · 2020
  4. Relative frequency of cardiology vs. endocrinology visits by type 2 diabetes patients with cardiovascular disease in the USA: implications for implementing evidence-based use of glucose-lowering medicationsCardiovascular Endocrinology & Metabolism · 2020
  5. Sociodemographic and metabolic risk characteristics associated with metabolic weight categories in the Women’s Health InitiativeCardiovascular Endocrinology & Metabolism · 2020
  6. A focused review of cardiovascular guideline related recommendations for the primary care physician in the USACardiovascular Endocrinology & Metabolism · 2020
  7. Relationship between a single measurement at baseline of body mass index, glycated hemoglobin, and the risk of mortality and cardiovascular morbidity in type 2 diabetes mellitusCardiovascular Endocrinology & Metabolism · 2020
  8. Associations of adiponectin and leptin with brain natriuretic peptide in African Americans: the Jackson Heart StudyCardiovascular Endocrinology & Metabolism · 2020
  9. Pathogenesis and remission of type 2 diabetes: what has the twin cycle hypothesis taught us?Cardiovascular Endocrinology & Metabolism · 2020
  10. The systemic implication of novel non-statin therapies in cardiovascular diabetology: PCSK9 as a case modelCardiovascular Endocrinology & Metabolism · 2020
  11. Possible molecular and paracrine involvement underlying the pathogenesis of COVID-19 cardiovascular complicationsCardiovascular Endocrinology & Metabolism · 2020
  12. Prevention and management of cardiovascular disease in patients with diabetes: current challenges and opportunitiesCardiovascular Endocrinology & Metabolism · 2020
  13. A treatment-based algorithm for identification of diabetes type in the National Health and Nutrition Examination SurveyCardiovascular Endocrinology & Metabolism · 2020
  14. Comparing inpatient costs of heart failure admissions for patients with reduced and preserved ejection fraction with or without type 2 diabetesCardiovascular Endocrinology & Metabolism · 2020
  15. Effects of aerobic and anaerobic exercise on glucose tolerance in patients with coronary heart disease and type 2 diabetes mellitusCardiovascular Endocrinology & Metabolism · 2020
  16. Acute hyperglycemia and contrast-induced nephropathy in patients with non-ST elevation myocardial infarctionCardiovascular Endocrinology & Metabolism · 2020
  17. Cardiometabolic disease in the older person: prediction and prevention for the generalist physicianCardiovascular Endocrinology & Metabolism · 2020
  18. The comparison of the relationships about the presence of branch retinal vein occlusion and endothelial functions between diabetic and non-diabetic patientsCardiovascular Endocrinology & Metabolism · 2019
  19. Estimation of apolipoprotein A in early onset ST-segment elevation myocardial infarctionCardiovascular Endocrinology & Metabolism · 2019
  20. Ventricular fibrillation associated with Graves' disease and amiodarone induced thyrotoxicosisCardiovascular Endocrinology & Metabolism · 2019
  21. Left ventricular mass index and subendocardial myocardial function in children with chronic kidney disease, a transmural strain and three-dimensional echocardiographic studyCardiovascular Endocrinology & Metabolism · 2019
  22. Cardioprotective diabetes drugs: what cardiologists need to knowCardiovascular Endocrinology & Metabolism · 2019
  23. Relative fat mass is a better predictor of dyslipidemia and metabolic syndrome than body mass indexCardiovascular Endocrinology & Metabolism · 2019
  24. Association of neutrophil-gelatinase-associated lipocalin with microvascular complications in patients with type 2 diabetes: a cross-sectional studyCardiovascular Endocrinology & Metabolism · 2019
  25. Atherosclerosis: integration of its pathogenesis as a self-perpetuating propagating inflammation: a reviewCardiovascular Endocrinology & Metabolism · 2019
  26. Correlation between the serum procalcitonin level and the extension and severity of coronary artery disease in patients with non-ST-segment elevation myocardial infarctionCardiovascular Endocrinology & Metabolism · 2019
  27. Vascular disease in the lower limb in type 1 diabetesCardiovascular Endocrinology & Metabolism · 2019
  28. The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about itCardiovascular Endocrinology & Metabolism · 2019
  29. Cardiovascular disease in type 1 diabetesCardiovascular Endocrinology & Metabolism · 2019
  30. Association between asymmetric dimethylarginine serum levels and left ventricular longitudinal deformation in patients with normal ejection fractions: a two-dimensional speckle-tracking echocardiography examinationCardiovascular Endocrinology & Metabolism · 2018
  31. Development of clinical trials to extend healthy lifespanCardiovascular Endocrinology & Metabolism · 2018
  32. Vitamin D status in acute myocardial infarction: a case–control studyCardiovascular Endocrinology & Metabolism · 2018
  33. In-vivo metabolic studies of regional adipose tissueCardiovascular Endocrinology & Metabolism · 2018
  34. Interaction between cardiovascular autonomic control and sex hormones in perimenopausal women under menopausal hormone therapyCardiovascular Endocrinology & Metabolism · 2018
  35. Is diabetes mellitus equivalent to atherosclerotic cardiovascular disease from a healthcare cost perspective? Insights from the Medical Expenditure Panel Survey: 2010–2013Cardiovascular Endocrinology & Metabolism · 2018
  36. Milk and dairy foods: implications for cardiometabolic healthCardiovascular Endocrinology & Metabolism · 2018
  37. The role of OPG/RANKL in the pathogenesis of diabetic cardiovascular diseaseCardiovascular Endocrinology & Metabolism · 2018
  38. Diagnostic challenges in supraventricular tachycardia: anticipating value of natriuretic peptidesCardiovascular Endocrinology & Metabolism · 2018
  39. Pathophysiology of cardiovascular disease in diabetes mellitusCardiovascular Endocrinology & Metabolism · 2018
  40. Mechanism of cardiovascular disease benefit of glucagon-like peptide 1 agonistsCardiovascular Endocrinology & Metabolism · 2017
  41. The relationship between serum endocan levels and the presence/severity of isolated coronary artery ectasiaCardiovascular Endocrinology & Metabolism · 2017
  42. Glycemic variability is associated with myocardial damage in nondiabetic patients with ST-elevation myocardial infarctionCardiovascular Endocrinology & Metabolism · 2017
  43. Advances in the relationship between Kruppel-like factor 15 and cardiovascular disease researchCardiovascular Endocrinology & Metabolism · 2017
  44. Heart failure: an underestimated therapeutic target in diabetesCardiovascular Endocrinology & Metabolism · 2017
  45. The impact of glucose-lowering medications on cardiovascular diseaseCardiovascular Endocrinology & Metabolism · 2017
  46. Hypertension and bradykininCardiovascular Endocrinology & Metabolism · 2012
  47. Natriuretic peptide infusion reduces myocardial injury during acute ischemia/reperfusionCardiovascular Endocrinology & Metabolism · 2012